PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 9, 2026ESMO Open0 citationsOpen Access

Prognostic nomogram for patients with HER2-negative metastatic gastric cancer receiving first-line PD-1 blockade

View Full Paper
BFB. FuMZM. ZhangTFT. Fang

Key Points

  • To develop a personalized prognostic nomogram for predicting survival in patients with HER2-negative metastatic gastric cancer receiving PD-1 blockade therapies.
  • Developed a nomogram for survival prediction
  • Focused on patients with HER2-negative metastatic gastric cancer
  • Utilized data from clinical outcomes of PD-1 blockade therapies
  • The nomogram accurately stratified patients by different survival risks
  • Provided individualized survival predictions

Abstract

The nomogram provided personalized survival prediction for patients with HER2-negative mGC receiving first-line PD-1 blockade-based therapies and enabled prognostic stratification to identify patients with different survival risks.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fu et al. (2026) studied this question.

synapsesocial.com/papers/69897983f0ec2af6756e7357https://doi.org/10.1016/j.esmoop.2025.106055
Ask AI
Helpful
Bookmark
Share
View Full Paper